LONDON, UK: IP Group plc (LSE: IPO) portfolio company Microbiotica Ltd, a leading player in discovering and developing microbiome-based therapeutics and biomarkers, has completed its £50m Series B financing round, the largest microbiome-related financing in Europe to date. The financing round was also supported by new investors Flerie Invest, Tencent and British Patient Capital as well as existing investors…
All posts tagged portfolio company
Arix Bioscience founds new portfolio company, Twelve Bio
LONDON: Arix Bioscience Plc, a global venture capital company focused on investing in and building breakthrough biotech companies, announced the foundation of a new portfolio company, Twelve Bio, which is developing novel engineered Cas12a nucleases for therapeutic gene editing. Arix is the sole investor in the company, with a 49% ownership stake. Twelve Bio is…